Integrated Motor-Cognitive Training in Parkinson's Disease

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This feasibility study enrolls 12 people with Parkinson’s disease to try a 10-session program that blends digital cognitive stimulation with group motor training. The aim is to assess how acceptable and practical the integrated approach is and to gather preliminary signals of efficacy. Participants have motor symptoms, MoCA scores of 18 or higher, and can participate in both components. The study will measure adherence, tolerability, and initial clinical outcomes related to motor and cognitive function. No definitive conclusions about effectiveness are planned from this phase.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Diagnosis of Parkinson's disease
* Presence of motor symptoms attributable to Parkinson's disease
* Availability to participate in both treatments (cognitive and motor)
* Severity of symptoms compatible with participation in group physical therapy
* Absence of other medical conditions that could interfere with treatment delivery
* Montreal Cognitive Assessment (MoCA) score \>= 18
* Consent to participate in group-based motor training
* Absence of falls in the 3 months prior to baseline evaluation

Exclusion Criteria:

* Concomitant major neurological or psychiatric disorders
* Severe cardio-pulmonary, renal, or hepatic diseases
* Changes in baseline pharmacological therapy within 3 months prior to enrollment

Where it's running

• Ferrara University Hospital
  Ferrara, Fe, Italy Recruiting

Study contacts

• Study coordinator: Sofia Straudi, MD, PhD
• Email: sofia.straudi@unife.it
• Phone: +390532238720

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• UX-DA003 injections for Parkinson's disease

  This early-phase trial tests whether injecting UX-DA003 is safe and may help motor symptoms in people with Parkinson's whose response to standard treatments has declined.

  Recruiting Early Phase 1 The First Affiliated Hospital of Anhui Medical University · Hefei, Anhui · NCT07911670

• Strength and dual-task training to help people with Parkinson’s improve strength and function

  This trial tests three levels of physiotherapy, including progressive resistance training with and without cognitive dual-task and instability components, to see if they improve muscle strength, body composition, and physical function in adults with Parkinson’s or related syndromes.

  Recruiting University of Valencia · Valencia, Valencia · NCT07907302

• Spinal Mobility, Rigidity, and Kinesiophobia in Parkinson's Disease with and without TMD

  This study tests whether people with Parkinson's disease who have Temporomandibular Disorders differ in spinal mobility, axial rigidity, and kinesiophobia from those without TMD.

  Recruiting Mustafa Kemal University · Hatay · NCT07850674

• A 12-Week Trial of Flexilev with the OraFID Device and App for Parkinson's

  This study tests whether taking small, precise doses of Flexilev with the OraFID dosing device and Levilog app is acceptable and helps people with Parkinson's manage their medicine.

  Recruiting at 2 sites Phase 4 Navamedic AB · Stockholm, Stockholm County and 4 other locations · NCT07839793

• VIM0423 for Parkinson's Tremor in Adults Not Fully Controlled by Dopaminergic Therapy

  A Vima Therapeutics study tests whether the oral drug VIM0423 can reduce tremor in adults with Parkinson’s disease who still have tremor despite dopaminergic treatment.

  Recruiting at 4 sites Phase 2 Vima Therapeutics · Scottsdale, Arizona and 29 other locations · NCT07804615

• Optimizing Adaptive Deep Brain Stimulation for Parkinson's Disease

  This study tests whether using ongoing brain signals gathered during daily life can improve adaptive deep brain stimulation for people with Parkinson's who have motor fluctuations.

  Recruiting University of California, Davis · Davis, California · NCT07798271

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.